Related Experiment Video
Updated: Apr 22, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Altered immune function in demyelinative disease
1Dale E. McFarlin is Chief, Neuroimmunology Branch, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, U.S.A.
Abstract:
Experimentally induced demyelination has an autoimmune origin in some mouse models and is somehow virally induced in others. In June, invited participants in a Kroc Foundation workshop discussed the damaging mechanisms involved and their relevance to an understanding of multiple sclerosis and human encephalomyelitis.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cell-mediated Immune Responses

